Complement Inactivation Strategy of Staphylococcus aureus Using Decay-Accelerating Factor and the Response of Infected HaCaT Cells

被引:8
|
作者
Jang, Kyoung Ok [1 ]
Lee, Youn Woo [1 ]
Kim, Hangeun [2 ]
Chung, Dae Kyun [1 ,2 ,3 ]
机构
[1] Kyung Hee Univ, Grad Sch Biotechnol, Yongin 17104, South Korea
[2] Skin Biotechnol Ctr Inc, Res & Dev Ctr, Yongin 17104, South Korea
[3] Kyung Hee Univ, Skin Biotechnol Ctr, Suwon 16229, South Korea
关键词
Staphylococcus aureus; decay-accelerating factor; internalization; ESAT-6-like protein EsxB; UL16 binding protein 1; tight junction;
D O I
10.3390/ijms22084015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Staphylococcus aureus is a species of Gram-positive staphylococcus. It can cause sinusitis, respiratory infections, skin infections, and food poisoning. Recently, it was discovered that S. aureus infects epithelial cells, but the interaction between S. aureus and the host is not well known. In this study, we confirmed S. aureus to be internalized by HaCaT cells using the ESAT-6-like protein EsxB and amplified within the host over time by escaping host immunity. S. aureus increases the expression of decay-accelerating factor (CD55) on the surfaces of host cells, which inhibits the activation of the complement system. This mechanism makes it possible for S. aureus to survive in host cells. S. aureus, sufficiently amplified within the host, is released through the initiation of cell death. On the other hand, the infected host cells increase their surface expression of UL16 binding protein 1 to inform immune cells that they are infected and try to be eliminated. These host defense systems seem to involve the alteration of tight junctions and the induction of ligand expression to activate immune cells. Taken together, our study elucidates a novel aspect of the mechanisms of infection and immune system evasion for S. aureus.
引用
收藏
页数:15
相关论文
共 26 条
  • [1] The Intrinsic Complement Regulator Decay-Accelerating Factor Modulates the Biological Response to Vascular Injury
    Sakuma, Masashi
    Morooka, Toshifumi
    Wang, Yunmei
    Shi, Can
    Croce, Kevin
    Gao, Huiyun
    Strainic, Michael
    Medof, M. Edward
    Simon, Daniel I.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (06) : 1196 - U265
  • [2] How endothelial cells protect themselves from complement by expressing decay-accelerating factor (DAF)
    Frances Williams
    Arthritis Research & Therapy, 3 (1)
  • [3] Fish decay-accelerating factor (DAF) regulates intestinal complement pathway and immune response to bacterial challenge
    Zhang, Xia
    Zhang, Yuhan
    Wu, Ting
    He, Hao
    Peng, Ran
    Jin, Kelan
    Mo, Huilan
    Qu, Fufa
    Tang, Jianzhou
    Zhou, Yonghua
    Yang, Yalin
    Zhou, Zhigang
    Fan, Junde
    Li, Jianzhong
    Liu, Zhen
    FISH & SHELLFISH IMMUNOLOGY, 2024, 151
  • [4] DECAY-ACCELERATING FACTOR REGULATES COMPLEMENT-MEDIATED DAMAGE IN THE HUMAN ATHEROSCLEROTIC WALL
    NICULESCU, F
    RUS, HG
    VLAICU, R
    IMMUNOLOGY LETTERS, 1990, 26 (01) : 17 - 23
  • [5] Tears contain the complement regulator CD59 as well as decay-accelerating factor (DAF)
    Cocuzzi, E
    Szczotka, LB
    Brodbeck, WG
    Bardenstein, DS
    Wei, T
    Medof, ME
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (02) : 188 - 195
  • [6] EXPRESSION OF DECAY-ACCELERATING FACTOR IS REDUCED ON HYPERPLASTIC SYNOVIAL LINING CELLS IN RHEUMATOID SYNOVITIS
    ITOH, J
    NOSE, M
    FUJITA, T
    KATO, M
    OHYAMA, A
    KYOGOKU, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 83 (03) : 364 - 368
  • [7] DECAY-ACCELERATING FACTOR (CD55) PROTECTS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM INACTIVATION BY HUMAN-COMPLEMENT
    MARSCHANG, P
    SODROSKI, J
    WURZNER, R
    DIERICH, MP
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (01) : 285 - 290
  • [8] HOMOLOGOUS RESTRICTION OF COMPLEMENT-MEDIATED CELL-LYSIS CAN BE MARKEDLY ENHANCED BY BLOCKING DECAY-ACCELERATING FACTOR
    ZHONG, RK
    KOZII, R
    BALL, ED
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 269 - 274
  • [9] PROTECTION OF GERMINAL-CENTERS FROM COMPLEMENT ATTACK - DECAY-ACCELERATING FACTOR (DAF) IS A CONSTITUTIVE PROTEIN ON FOLLICULAR DENDRITIC CELLS - A STUDY IN REACTIVE AND NEOPLASTIC FOLLICLES
    LAMPERT, IA
    SCHOFIELD, JB
    AMLOT, P
    VANNOORDEN, S
    JOURNAL OF PATHOLOGY, 1993, 170 (02) : 115 - 120
  • [10] Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity
    Guo, Bo
    Ma, Zheng-wei
    Li, Hua
    Xu, Gui-lian
    Zheng, Ping
    Zhu, Bo
    Wu, Yu-Zhang
    Zou, Qiang
    CLINICAL IMMUNOLOGY, 2008, 128 (02) : 155 - 163